Exicure (XCUR) Shareholder's Equity Growth (1y) (2017 - 2026)
Exicure (XCUR) Shareholder's Equity Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Exicure |
19.38 Mn |
16.77 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-81.57% |
| Dec 31, 2025 |
-42.03% |
| Sep 30, 2025 |
348.35% |
| Jun 30, 2025 |
449.47% |
| Mar 31, 2025 |
415.72% |
| Dec 31, 2024 |
123.42% |
| Sep 30, 2024 |
-65.65% |
| Jun 30, 2024 |
-83.38% |
| Mar 31, 2024 |
-84.90% |
| Dec 31, 2023 |
-79.69% |
| Sep 30, 2023 |
221.47% |
| Jun 30, 2023 |
734.48% |
| Mar 31, 2023 |
351.76% |
| Dec 31, 2022 |
32.85% |
| Sep 30, 2022 |
-126.48% |
| Jun 30, 2022 |
-96.83% |
| Mar 31, 2022 |
-93.53% |
| Dec 31, 2021 |
-81.74% |
| Sep 30, 2021 |
-80.96% |
| Jun 30, 2021 |
-55.18% |
